(P116) Utilization of Nonsteroidal MRA Finerenone: Evaluation of Real-World Data in the United States, 2021–2023

This poster describes the utilization of finerenone, in patients with CKD and T2D, 2 years after its approval through a cross-sectional study using data from the Veradigm Network electronic health record spanning August 1, 2016–September 30, 2023.